Tenaya Therapeutics Inc.
(TNYA)
undefined
undefined%
At close: undefined
2.78
1.14%
Pre-market Dec 16, 2024, 04:37 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Net Income | -124.08M | -123.67M | -72.72M | -38.40M | -26.23M |
Depreciation & Amortization | 8.69M | 6.47M | 2.96M | 2.48M | 1.99M |
Stock-Based Compensation | 15.31M | 11.47M | 2.95M | 741.00K | 414.00K |
Other Working Capital | -2.37M | -2.51M | -3.86M | -376.00K | -647.00K |
Other Non-Cash Items | 3.66M | 2.16M | 1.06M | -75.00K | 64.00K |
Deferred Income Tax | - | - | 192.00K | 33.00K | -82.00K |
Change in Working Capital | -5.65M | -849.00K | 4.74M | -234.00K | -250.00K |
Operating Cash Flow | -102.07M | -104.42M | -60.81M | -35.45M | -24.10M |
Capital Expenditures | -1.24M | -20.63M | -25.12M | -9.76M | -2.93M |
Acquisitions | - | - | - | - | 2.66K |
Purchase of Investments | -56.64M | -140.48M | -213.44M | - | -12.66M |
Sales Maturities Of Investments | 106.62M | 244.75M | - | 2.75M | 10.00M |
Other Investing Acitivies | -25.00K | 8.00K | -213.44K | 2.75K | -2.66K |
Investing Cash Flow | 48.72M | 83.65M | -238.56M | -7.01M | -5.58M |
Debt Repayment | - | - | - | - | - |
Common Stock Repurchased | - | - | -13.00K | -1K | -3.00K |
Dividend Paid | - | - | - | - | - |
Other Financial Acitivies | 181.00K | 380.00K | 20.44M | 147.27M | 30.51M |
Financial Cash Flow | 4.05M | 77.77M | 208.97M | 147.27M | 30.51M |
Net Cash Flow | -49.31M | 56.99M | -90.41M | 104.81M | 832.00K |
Free Cash Flow | -103.31M | -125.05M | -85.93M | -45.21M | -27.02M |